CTCs from breast cancer patients formed aggregates with platelets and displayed evidence of TGFβ pathway activation [23], which is consistent with our observation that UM-UC3 CTC's were clustered on the blood smear and expressed downstream mediators of TGFβ signaling. The gene discussed is TGFB1; the disease is breast cancer.